2023 Full-year results
Wesfarmers Health outlook
•
•
.
•
Wesfarmers Health has a complementary portfolio of health,
wellbeing and beauty assets and is well positioned to deliver
long-term growth and capitalise on health sector tailwinds
Near-term market conditions expected to remain challenging
Wesfarmers Health continues to actively manage the impact
of cost inflation, including rising labour costs, together with
changes to the PBS1, and implications of the recent
announcement of 60-day dispensing of PBS medicines
Wesfarmers Health remains focused on delivering actions as
part of the 'Accelerate' transformation plan:
-
Investment will continue to strengthen the Priceline offer,
expand the franchise store network, reset the wholesale
proposition and optimise the supply chain
Development of the new fully-automated fulfilment centre in
Brisbane will continue, with construction commenced in
May 2023
The division continues to pursue logical expansion
opportunities across digital health, medical aesthetics and
wholesale pharmaceutical
Recently completed acquisition of InstantScripts in
July 2023
Proposed acquisition of SILK Laser Australia
Clear Skincare
1. Pharmaceutical Benefits Scheme.
2023 Full-year results | 51View entire presentation